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Background: Vitamin D is essential for bone mineralization, particularly in premature infants. For nearly 20 years,
Quebec has offered a program of free vitamin D supplements via its public medication insurance plan Régie de
l’Assurance Maladie du Québec (RAMQ). The objective of this study is to evaluate the number of preterm infants that
obtained at least one bottle (50 doses) of vitamin D supplement through this program and to determine if uptake
varied by gestational age.
Methods: This was a retrospective cohort study of preterm infants covered by RAMQ and born from 1998 to 2008;
all infants had 1 year of follow-up data regarding supplement use. Data were extracted from the Quebec Pregnancy
Cohort, a linked administrative database and were stratified by early (<34 weeks) or late gestational age premature
infants. The number of infants obtaining supplements was the primary outcome and their characteristics were
compared across gestational age groups. Predictors for participation (obtaining at least 1 bottle) or adherence
(2 or more bottles) were identified via logistic regression (GEE).
Results: 10288 infants were eligible; the percentage exposed to vitamin D was 24.5% (37.4%- early; 20.7%-late
preterm infants, p < 0.001). The median number of bottles obtained was 2 for early and 1 for late preterms. For all
premature infants, there was an apparent geometric decline in the infants obtaining subsequent bottles of
supplements over the 12 month period. Additionally, there was a significant decline in program participation over
time (OR = 0.90/year, 95% CI: 0.89-0.90) regardless of gestational age. Older or more educated mothers were
positive predictors for participation. A prescription from a pediatrician significantly increased the odds of obtaining
the supplement.
Conclusion: Early preterm infants were more likely to obtain the supplement post-discharge; uptake was low and
decreased with time for both age categories. Specifically, targeting late preterm infants and young mothers with
less education could improve vitamin D uptake.
Keywords: Premature infants, Vitamin D, Supplementation, Mineralization, Fractures, Early preterm, Socioeconomic
status, EducationBackground
Preterm infants are at risk for bone health issues; the
third trimester is a period of enhanced mineral transfer
from mother and rapid bone mass accrual [1,2]. Since
postnatal nutritional support cannot replicate the rich in
utero environment, preterm infants may have fragility* Correspondence: crodd@hsc.mb.ca
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unless otherwise stated.fractures before and after discharge; fracture rates range
from 2-10% [1,2]. Measures to reduce such complica-
tions include special formulas or breast milk fortified
with minerals, vitamins and protein [1,2]. Consensus
has not yet been achieved on the dosage of vitamin D
that preterm infants should receive but all preterm
infants should receive a supplement as per established
guidelines. European recommendations of 800–1000 IU/
day are about double North American recommenda-
tions of 400 IU/d [3,4]. Many infants, particularly youngtd. This is an Open Access article distributed under the terms of the Creative
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formula to meet these recommendations, and breast fed
infants also require supplementation because of the low
concentration of vitamin D in breast milk [5]. Hence,
there is a need for vitamin D supplementation for all
preterm infants regardless of feeding modality.
Different jurisdictions promote vitamin D supplemen-
tation with various strategies; nevertheless, success has
been variable and barriers still exist. In the UK, a system
of coupons exchangeable for bottles of vitamin D has
been instituted by the National Health Service (NHS)
and has partially succeeded [6]. Turkey provides vitamin
D via prescription [7]. We have recently reported that
the province of Quebec has for 20 years utilized a pro-
gram of free supplements via prescription without a
major educational component [8]. Participation (obtaining
1 or more bottles) was limited to only 18% of full term in-
fants during the period 1998–2009. Vitamin D exposure to
infants declined over time in the face of a doubling of ex-
clusive breastfeeding for the first 6 mo. of age from 2003-
2009 [9]. This appeared to translate into a modest increase
in the number of cases of rickets over this time [8].
The objective of this study is to evaluate the number of
preterm infants that obtained at least one bottle (50 doses)
of vitamin D supplement through this program and to de-
termine if uptake varied by gestational age., using a linked
administrative database (Quebec Pregnancy Cohort or
QPC) [10]. We anticipated that the participation would
be low, similar to term infants. Secondary objectives in-
cluding assessing whether uptake by early preterm in-
fants (born <34 weeks) might be different than infants
born closer to term (late preterm 34- 366/7 weeks)
[11]. Long term adherence (obtaining 2 or more bot-
tles) was also examined, as were likely predictors, such
as maternal education and physician specialty provi-
ding the prescription, which we have previously identi-




This was a retrospective analysis of an annual birth cohort
of all preterm infants in Quebec born between January 1,
1998 and December 31, 2008. All data are obtained from
the QPC, a validated, comprehensive and continuing
population-based cohort [10,12,13]. This includes all
pregnancies of women covered by the Régie de l’Assurance
Maladie du Québec (RAMQ) medication insurance plan;
about 30% of all pregnant women are covered by RAMQ
while the rest have private group insurance. The QPC is
created from a linkage of 3 administrative data bases in-
cluding RAMQ (medical services and prescription claims),
MED-ECHO (hospitalizations) and Institut de la Statis-
tique du Québec (birth registry) using the maternal andchild provincial health record numbers, date of births and
names [10]. As described in more detail in the manuscript
concerning term uptake, information such as prescription
medications, socioeconomic status (SES), health care pro-
vider’s details, hospitalizations, and parental demographics
are available in the QPC [8].
In 1994, the first vitamin D preparation was placed on
the RAMQ formulary; this was free for social assistance
recipients. Since 1997, supplements have been free via
prescription for all participants of the RAMQ plan, with
comparable coverage provided by all private group in-
surance programs.
Patient eligibility included all preterm infants (born
<37 weeks) during the study period; these infants were
further subdivided into early (<34 weeks) and late pre-
term infants (34 to 366/7 weeks) [11]. Their mothers
needed to be covered by the RAMQ plan for the first
12 months post-delivery, and information about the
duration of hospitalization was required. Infants with
rare rachitic disorders such as renal failure, X-linked
hypophosphatemic rickets, and infants and mothers
treated with calcitriol were excluded using ICD-9 and
ICD-10 codes.
Data analysis
Our primary outcome was the number of preterm in-
fants participating in this free vitamin D program in
each calendar year between 1998 and 2009 (born 1998
till 2008 with at least 12 months of follow up). Participa-
tion was defined as a preterm infant obtaining at least
one bottle of vitamin D during the first year of life. Sec-
ondary outcomes included adherence to the program
(obtaining two or more prescription over the same time
period) and whether participation or adherence varied
by gestational age.
The insured vitamin preparations (400 IU/d of vitamin
D) are all 50 dose bottles (1 ml = 1dose); the prepara-
tions included D-Vi-Sol®, Jamp-Vitamin D® and PediaVit
D® and the multivitamin preparations Jamp-Vitamins A-
D-C®, PediaVit® and Tri-Vi-Sol®. Baby Ddrops® (1drop =
400 IU) were added to the formulary in late 2009 but
was not available during the study time frame.
Covariates for all outcomes include maternal age, post-
secondary education, living status (couple vs. single),
urban vs. rural, registrant vs. welfare recipient (RAMQ
status), calendar year, specialty of prescribing physician,
gestational age, birth weight, and sex of infant. Informa-
tion on feeding method, parity and ethnicity were not
available for use as potential confounders. The season of
procurement of the first bottle of supplement was in-
cluded to account for possible reliance on cutaneous pro-
duction of vitamin D; October1 to March 31 was deemed
the non-synthesizing period for vitamin D based on the
low zenith angle of the sun for Quebec [14].
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Descriptive statistics were used to compare the all pre-
terms exposed to vitamin D supplements vs. those who
were not. All analyses were repeated to determine if
these varied by gestational age. Results are expressed as
means and standard deviations or medians with range or
percentages as appropriate. Multivariate logistic regres-
sion models were utilized to assess temporal trends in
program participation and adherence and to identify
additional predictors for both participation and adher-
ence. Generalized estimating equations (GEE) were uti-
lized to account for familial clustering (by mothers).
Appropriate regression diagnostics were performed; stat-
istical analyses were done using SAS (SAS institute Inc.,
Version 9.2, Cary, NC, USA).
Ethics
The Research Ethics Committees at the Montreal Chil-
dren’s Hospital, McGill University Health Center and
CHU-Ste-Justine granted approval. The access to the
data used to create the Quebec Pregnancy Cohort was
authorized by the Commission d’Accès à l’Information
and approved by the CHU-Ste-Justine ethics committee.
Results
During the time frame of interest, 149307 infants were
born in Quebec; 11504 (7.7%) were born at less than
37 weeks gestational age. After applying eligibility
criteria, 10288 infants were available for analysis; the
majority of these were born late preterm (n = 7819).
Tables 1 and 2 present maternal, infant (Table 1) and
physician characteristics (Table 2) regarding uptake of
the free supplement program.Table 1 Characteristics of women and infants with respect to











Age, years, mean ± SD 27.7 ± 6.0 28.0 ± 6.1 0.284 28.1 ± 5
Welfare recipient, % (n) 26.5 (239) 25.7 (387) 0.669 27.7 (44
Mothers living
alone, % (n)
22.1 (199) 21.3 (321) 0.665 19.1 (30
Post-secondary education
level, % (n)
36.1 (326) 35.8 (539) 0.851 40.8 (66




30.4 ± 2.5 30.6 ± 2.7 0.25 35.3 ± 0
Weight at delivery,
grams, mean ± SD
1577.9 ± 711.8 1657.7 ± 612.5 < 0.001 2573.4 ±
Male gender, % (n) 52.6 (474) 54.9 (828) 0.252 50.9 (82Roughly a quarter (24.5%) of all preterms partici-
pated; a higher proportion of early preterms obtained
at least one bottle of vitamin D compared to those
born after 34 weeks (37.4% vs. 20.7%, p < 0.0001) Add-
itionally, a higher percentage of early preterm infants
were likely to obtain more than 1 bottle of supple-
ments via this program (61.6%) compared to late pre-
terms (49.7%, p <0.0001). The median number of
bottles procured was higher with 2 (range; 1–12) vs. 1
(range; 1–15) in those infants born earlier. The median
time to procure the first supplement was longer in
those born earlier (62 vs. 35 days). The only consistent
predictors in both groups (assessed separately or to-
gether) for participation (obtaining 1 or more bottles
over 12 mo) were specialty of infant’s physician and a
lesser weight at delivery (Table 3).
The single consistent predictor for ‘total’, early or late
premature infants was calendar year of delivery after ad-
justment; this was negatively associated (OR = 0.90 per
year, 95% CI: 0.89-0.90). For late and ‘total’ preterms,
higher maternal age, more education, prescription pro-
vided by a pediatrician or shorter duration of pregnancy
were positive predictors for participation after adjust-
ment for the other variables in the model. Adherence
(obtaining 2 or more prescriptions over 12 months
compared to those obtaining 1 prescription or no vita-
min D) was also explored using a multivariate logistic
regression (Table 4).
For both gestational age categories and ‘total’ pre-
terms, an older mother was positively associated, and
the year of delivery was negatively associated. When
evaluating adherence, the only positive predictors were
a mother with more education, a shorter duration ofvitamin D exposure in infancy













.9 27.7 ± 5.7 0.010 28.0 ± 6.0 27.8 ± 5.8 0.136
8) 24.0 (1490) 0.002 27.3 (687) 24.4 (1877) 0.003
9) 20.2 (1251) 0.337 20.2 (508) 20.4 (1572) 0.802
0) 35.4 (2193) < 0.001 39.1 (986) 35.4 (2732) < 0.001
66) 78.5 (4866) 0.845 77.8 (1960) 78.9 (6079) 0.259
.8 35.4 ± 0.7 < 0.001 33.6 ± 2.8 34.5 ± 2.4 < 0.001
552.8 2649.1 ± 477.6 < 0.001 2217.0 ± 777.9 2455.2 ± 641.4 < 0.001
3) 53.8 (3335) 0.044 51.5 (1297) 54.0 (4163) 0.037
Table 2 Characteristics of physicians prescribing and adherence and participation




















Specialty of the infants’ physician, % (n)
General Practitioner 23.9 (216) 17.7 (267) < 0.001 39.2 (635) 43.4 (2692) < 0.001 33.8 (851) 38.4 (2959) < 0.001
Paediatrician 73.5 (663) 53.8 (811) 57.5 (930) 47.7 (2958) 63.2 (1593) 48.9 (3769)
Obstetrician- Gynaecologist 0.3 (3) 0.0 (0) 1.2 (20) 0.0 (0) 0.91 (23) 0.0 (0)
Other specialist 2.2 (20) 28.5 (429) 2.0 (33) 8.9 (551) 2.1 (53) 12.7 (980)
% of infants obtaining 2 or more
bottles of Vitamin D (n)
61.6 (556) - - 49.7 (805) - - 54.0 (1361) - -
Among infants with 1 or more vitamin D
prescription
Age at the time of the first prescription.
days. median (min-max)
62 (8–397) - - 35 (1–400) - - 49 (2–400) -
Number of vitamin D prescriptions 2 (1–12) - - 1 (1–15) - - 2 (1–15) - -
median (min-max)
Infants initiating vitamin D during
non-synthesizing period ……….% (n)*
51.3 (463) - - 52.4 (848) - - 52.0 (1311) - -
*Non synthesizing period: October 1st to March 31st.
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and ‘total’ preterms.
The Figure 1 presents the number of infants obtaining 1
or more bottles; a steep drop was noted in the number of
infants obtaining 2 or more bottles over a 12 mo. period.
Discussion
Overall, preterm infants had low participation in the free
vitamin D program, with only ~25% of them obtaining
at least one bottle of supplement. Interestingly, nearly
twice the number of early preterm (born <34 weeks)Table 3 Predictors of participation in the vitamin D program
Characteristics Early preterm
OR
Maternal age (year) 1.00
Welfare recipient vs. adherent 0.84
Living alone vs. couple 1.10
Level of education: ≤12 years vs. >12 years 1.02
Rural vs. urban resident 1.22
Duration of pregnancy (week) 1.00
Birth weight (grams) 1.00
Male gender infants 1.02
Year of delivery 0.93
Non synthesizing* vs. synthesizing period 1.01
Infants followed up by General practitioner (reference)
Paediatrician 0.92
Other specialist 0.08
*Non synthesizing period: October 1st to March 31st.procured bottles via this program compared to late pre-
terms (37.4% vs. 20.7%). As previously noted, only 18.2%
of term infants from Quebec participated in this pro-
gram over the same time frame [8]. Both late preterm
and term infants also obtained a median number of 1
bottle (50 doses) of vitamin D during their 12 month fol-
low up, while those born at <34 weeks procured enough
(median) for 100 doses.
To date, there do not appear to be other manuscripts
evaluating the programs promoting vitamin D supple-
ments specifically in premature infants. Programs for all(infants with one or more prescription)
Late preterm Total
CI OR CI OR CI
0.98-1.01 1.01 1.00-1.02 1.01 1.00 - 1.02
0.67-1.05 1.12 0.97-1.29 1.05 0.93 – 1.19
0.89-1.37 0.93 0.80-1.09 0.99 0.87 – 1.12
0.84-1.23 0.77 0.68-0.87 0.83 0.75 – 0.93
0.97-1.53 1.04 0.90-1.19 1.08 0.96 – 1.22
0.93-1.09 0.88 0.81-0.96 0.91 0.88 – 0.95
1.00-1.00 1.00 1.00-1.00 1.00 1.00 – 1.00
0.86-1.21 0.95 0.85-1.06 0.97 0.88 – 1.07
0.91-0.96 0.89 0.87-0.90 0.90 0.89 – 0.92
0.84-1.22 1.07 0.95-1.20 1.06 0.96 – 1.17
0.74-1.16 1.23 1.09-1.39 1.21 1.09 - 1.35
0.05-0.12 0.41 0.31-0.55 0.20 0.16 - 0.27
Table 4 Predictors of adherence in the vitamin D program (infants obtaining 2 or more prescriptions)
Characteristics Early preterm Late preterm Total
OR CI OR CI OR CI
Maternal age (year) 1.03 1.01-1.05 1.03 1.02-1.05 1.03 1.02 – 1.04
Welfare recipient vs. adherent 0.81 0.62-1.05 1.06 0.88-1.28 0.98 0.84 – 1.15
Living alone vs. in couple 1.01 0.76-1.33 0.91 0.74-1.12 0.96 0.82 – 1.13
Level of education: ≤12 years vs. >12 years 0.92 0.75-1.14 0.76 0.64-0.89 0.81 0.71 – 0.93
Rural vs. urban resident 1.03 0.79-1.36 1.08 0.90-1.31 1.07 0.92 – 1.24
Duration of pregnancy (week) 0.98 0.90-1.06 0.84 0.76-0.94 0.91 0.88 - 0.95
Birth weight (grams) 1.00 1.00-1.00 1.00 1.00-1.00 1.00 1.00 – 1.00
Male gender infants 1.11 0.90-1.36 1.04 0.90-1.21 1.04 0.92 – 1.17
Year of delivery 0.94 0.90-0.97 0.90 0.88-0.92 0.91 0.89 - 0.93
Non synthesizing* vs. synthesizing period 1.07 0.87-1.32 1.02 0.87-1.19 1.03 0.91 – 1.16
Infants followed up by General practitioner (reference)
Paediatrician 1.08 0.84-1.39 1.29 1.09-1.52 1.27 1.11 - 1.45
Other specialist 0.11 0.06-0.19 0.47 0.32-0.69 0.23 0.16 - 0.32
*Non synthesizing period: October 1st to March 31st.
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success [7,15]; Turkey in particular has recently dramat-
ically reduced its rate of rickets (6.8% to 0.1%) and im-
proved the vitamin D status of its young children.
Despite comprehensive campaigning, Birmingham has
had a more moderate degree of success, with a tripling
of uptake (5% to 17%) [15]. Those born 35 weeks or
older in Quebec had a similar rate to Birmingham’s, but
without their educational component [15]. One might
speculate that promotional efforts like Birmingham’s
might increase uptake several fold. Steps such as inform-
ing all physicians that vitamin D is free of charge to fam-
ilies and measures at nurseries, local pharmacies and
physician’s offices are logical targets to advertise the pro-
gram and reinforce the need for vitamin D.Figure 1 Number of bottles of vitamin D supplements obtained overThis low utilization is at odds with the reports from
the Canadian Community Health Survey and 2 other
Canadian surveys, which typically addressed uptake of
vitamin D in healthy term infants [16-18]. The difference
may reflect biases in obtaining the data, such as recall
bias (increasing vitamin D utilization when parents were
surveyed) or that the 2 smaller surveys focused on urban
populations. Our findings may also have excluded fam-
ilies purchasing vitamin D over-the-counter due to the
failure of caregivers to provide prescriptions, beliefs that
breast milk is complete, or challenges administering the
available products.
Unfortunately, in all 3 groups (term, and 2 preterm
groups), there was a significant decline in participation
in the free program between 1998 and 2009 despite ainfancy in all preterm infants.
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6 mo (9 to 19% from 2003 to 2009) [8,9,16]. Older
mothers, those with more education, and a prescription
from a pediatrician increased the odds of both partici-
pation and adherence; there was a striking degree of
consistency amongst predictors across all gestational
ages, including term [7,8,19]. Because of the small num-
bers of early preterms, some of these predictors were
only significant in the late preterm or total group.
The participation rate and higher numbers of bottles
obtained in early preterms compared to late preterm or
older infants might suggest possible explanations: Some
NICUs or hospital nurseries may be promoting breast-
feeding or vitamin D differently in these groups; parents
and health-care givers may also perceive bone health risk
differently in these vulnerable infants [20-23].
Specifically some hospitals have developed Family Care
units with emphasis on breastfeeding promotion [23].
We hypothesize that these units may have placed par-
ticular emphasis on supplementation given that breast
milk typically has low concentrations of vitamin D [23].
Additionally, evidence that breast milk may prevent dis-
orders such as necrotizing enterocolitis or respiratory ill-
nesses may also increase breastfeeding, particularly in
those infants born at a younger gestational age [22].
Some literature suggests that late preterm infants are at
times sent home relatively quickly with perhaps less sup-
port for breastfeeding, which may result in an earlier
move to fortified formula [20,21]; this may then reduce
the promotion of vitamin D for near-term infants. Un-
fortunately, we are not aware of the specific feeding mo-
dality in our populations.
Differential uptake may also reflect actual fractures
or problems with mineral homeostasis during the hos-
pitalization, prompting parents of early preterm infants
to more eagerly adopt vitamin D supplements and con-
tinue them for a longer duration [1]. In general, parents
of preterm infants perceive them to be more vulnerable
than term infants, which may lead to more vigorous
utilization of vitamin supplements [24]. Detailed data at
an individual level were not available to us to support
these hypotheses.
Our data were too limited to evaluate the impact of
declining vitamin D uptake over time in just our pre-
term cohort; we previously reported the modest increase
in rickets between 1998 and 2009 in infants of all gesta-
tional age in the QPC [8]. Additionally, we cannot com-
ment in detail on the timing of procuring the first bottle
of supplements. In term infants, there was a significant
delay (median time was 36 d), which is similar to the
median delay of 35 d in late preterm infants [8]. We do
not know the age of discharge from hospital for the pre-
term infants, and the delay out to 66 d in the early pre-
terms likely represents longer hospital stays.Given the relatively better uptake in early preterm in-
fants; we need to understand what prompted these fam-
ilies to obtain the supplements, unlike parents of later
gestational infants. These observations and the previ-
ously described risk factors (younger mothers and those
of lower SES) may allow Quebec and other jurisdiction
to focus efforts to increase supplementation rates [7,8].
Moreover, because premature infants are at risk for fra-
gility fractures out to 1-2y of life and there is still uncer-
tainty about their optimal intake; 400 IU/d seems to be a
reasonable target [25]. The utilization of special prema-
ture infant formula enriched in vitamin D and minerals
post-discharge might replace the need for supplementa-
tion, but this, remains controversial [2].
There are some limitations with our data, such as not
knowing the breastfeeding status of the infants, if the
families received a prescription, if they actually adminis-
tered the supplements once procured, or if they obtained
vitamin D outside of the free program. The latter would
still be perceived to be a failure of the program.
Conclusion
All preterm infants had low uptake of the free supple-
ment program, but early preterms demonstrated higher
participation rates and better adherence. This would
suggest that hospital-based interventions can improve
vitamin D supplement uptake. Clearly, additional tar-
geted reinforcement is warranted because preterm in-
fants remain at risk for fragility fractures, and infants of
young mothers with low education levels had lower
levels of participation in the program [26]. Moreover,
free vitamin D by prescription is clearly not sufficient
without additional reinforcement; endorsement from a
pediatrician appears to be particularly beneficial. These
data help identify vulnerable infants and families that re-
quire additional support to promote adequate vitamin D
intake.
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